Tag: Developing

Innovation, Research

Developing a COVID-19 antigen test

May 15, 2020

Via: The Medical News

Avacta is developing cancer immunotherapeutics, and diagnostics, based on its Affimer technology. The Affimer® platform is an alternative to antibodies derived from a small human protein, designed to address many of the shortcomings and negative performance issues associated with antibodies, […]